✦ LIBER ✦
Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI – Mel.A.) [ISRCTN75125874]
✍ Scribed by Vanna Chiarion-Sileni; Paola Del Bianco; Antonella Romanini; Michele Guida; Adriano Paccagnella; Maurizio Dalla Palma; Emanuele Naglieri; Ruggero Ridolfi; Barbara Silvestri; Maria Michiara; Gian Luca De Salvo
- Book ID
- 115010939
- Publisher
- BioMed Central
- Year
- 2006
- Tongue
- English
- Weight
- 407 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1471-2407
No coin nor oath required. For personal study only.